Article
Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19.
British journal of clinical pharmacology - 1 May 1995
Chang M, Tybring G, Dahl M L, Götharson E, Sagar M, Seensalu R, Bertilsson L
Abstract excerpt
1. Fourteen healthy Swedish Caucasian subjects were given 20 mg of omeprazole orally each morning for 8 days. The subjects included five poor metabolisers (PM) of S-mephenytoin, four heterozygous extensive metabolisers (hetEM) and five subjects with a very rapid metabolism (rapidEM). 2. After the first dose, the relative mean areas under the plasma concentration vs time curve (AUC) of omeprazole in rapidEM, hetEM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
